Search - tctmd.com

Displaying 761 - 780 of 1332

Sort: Relevancy | Date

Presentation TCT 2016

Turkey Presents: Strategies to Limit Reperfusion Injury in ACS patients

Presenter: Murat Sezer, Niels van Royen

October 31, 2016

Presentation TCT 2016

DEB: What Are the Potential Indications?

Presenter: Guy J. Friedrich, Kurt Huber, Eduard Margetic

October 31, 2016

Presentation TCT 2016

BVS in Complex Lesions: Ready or Not?

Presenter: Guy J. Friedrich, Kurt Huber

October 31, 2016

Presentation TCT 2016

Rotablation: What Are the Current Indications?

Presenter: Guy J. Friedrich, Kurt Huber, Walter Desmet

October 31, 2016

Presentation TCT 2016

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

Presenter: A. Pieter Kappetein, Allan Schwartz, James B. Hermiller Jr.

October 30, 2016

Presentation TCT 2016

TCT 115: Clinical features and Outcomes in Patients with Acute Coronary Syndrome Complicated by Cardiogenic Shock Supported with Extracorporeal Membrane Oxygenation, Single Center Experience

Presenter: Simon R. Dixon, Kirk N. Garratt

October 30, 2016

Presentation TCT 2016

TCT 100: Asians Suffer the Highest In-Hospital Mortality Rates After Acute Coronary Syndrome Despite High Use of Early Invasive Procedures

Presenter: Laurent Bonello, David Erlinge

October 30, 2016

News Industry News

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

October 30, 2016

Presentation TCT 2016

ACS Case Presentation: Where Pharmacotherapy Failed

Presenter: C. Michael Gibson, Daniel I. Simon, Gennaro Giustino

October 30, 2016

Presentation TCT 2016

Limitations of Pharmacotherapy Clinical Trial Design

Presenter: C. Michael Gibson, Daniel I. Simon, Sanjay Kaul

October 30, 2016

Presentation TCT 2016

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With STEMI

Presenter: C. Michael Gibson, Daniel I. Simon, Sunil V. Rao

October 30, 2016

Presentation TCT 2016

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With NSTE-ACS

Presenter: C. Michael Gibson, Daniel I. Simon, Glenn N. Levine

October 30, 2016

Presentation TCT 2016

Acute Coronary Syndromes: STEMI

Presenter: Peter Barlis, Grzegorz L. Kaluza, Michael C. Kim

October 29, 2016

Presentation TCT 2016

Acute Coronary Syndromes: NSTE-ACS

Presenter: Peter Barlis, Grzegorz L. Kaluza, Ziad A. Ali

October 29, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR In Acute Coronary Syndromes

Presenter: Colin Berry

October 28, 2016

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Shelley Wood

October 07, 2016

News Daily News

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

Yael L. Maxwell

October 05, 2016

News Daily News

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Shelley Wood

October 03, 2016

News Daily News

比伐卢定和普通肝素对有无 ST 段抬高的 ACS 患者没有任何差异：MATRIX

Shelley Wood

October 03, 2016

Advertisement

Turkey Presents: Strategies to Limit Reperfusion Injury in ACS patients

DEB: What Are the Potential Indications?

BVS in Complex Lesions: Ready or Not?

Rotablation: What Are the Current Indications?

Aortic Stenosis + Concomitant Disease II. TAVR in Patients With Acute and Chronic Coronary Syndromes - When and How Much to Treat

TCT 115: Clinical features and Outcomes in Patients with Acute Coronary Syndrome Complicated by Cardiogenic Shock Supported with Extracorporeal Membrane Oxygenation, Single Center Experience

TCT 100: Asians Suffer the Highest In-Hospital Mortality Rates After Acute Coronary Syndrome Despite High Use of Early Invasive Procedures

Very Thin-Strut Biodegradable Polymer Everolimus-Eluting And Sirolimus-Eluting Stents Shown To Be Non-Inferior To Durable Polymer Zotarolimus-Eluting Stents In All-Comers With Coronary Artery Disease

ACS Case Presentation: Where Pharmacotherapy Failed

Limitations of Pharmacotherapy Clinical Trial Design

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With STEMI

Unmet Needs and Data Gaps for Pharmacotherapy in Patients With NSTE-ACS

Acute Coronary Syndromes: STEMI

Acute Coronary Syndromes: NSTE-ACS

FFR In Acute Coronary Syndromes

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

On the Frontier of CTO PCI for STEMI Patients: Answers Lead to More Questions in EXPLORE

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

比伐卢定和普通肝素对有无 ST 段抬高的 ACS 患者没有任何差异：MATRIX

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content